The Gates Biomanufacturing Facility at CU Anschutz Medical Campus is a 20,000 square ft. GMP compliant facility that provides cell-based therapies and protein biologics for use in preclinical investigations and Phase I and Phase II human clinical trials. The GBF was established through partnership with the Gates Center for Regenerative Medicine, University of Colorado Health, Children's Hospital Colorado, University of Colorado-School of Medicine, and the Gates Frontiers Fund.
